Trials / Unknown
UnknownNCT04955756
Early Identification and Severity Prediction of Acute Respiratory Infectious Disease
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 440 (estimated)
- Sponsor
- Huashan Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Early identification and Severity prediction of Acute Respiratory infectious disease has become a top priority for clinicians at department of infectious and respiratory diseases after COVID-19 broke out. This is a multicenter, prospective, and randomized study, which aims to figure out the best way of early identification and severity prediction of acute respiratory infectious diseases. Patients with suspected acute respiratory infectious diseases will be enrolled into this study and received two different diagnostic pathways.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | mNGS | Participants will be randomized to receive mNGS or multiplex PCR for diagnosis at enrollment. |
| DIAGNOSTIC_TEST | Multiplex PCR | Participants will be randomized to receive mNGS or multiplex PCR for diagnosis at enrollment. |
Timeline
- Start date
- 2021-04-04
- Primary completion
- 2024-12-31
- Completion
- 2024-12-31
- First posted
- 2021-07-09
- Last updated
- 2022-05-12
Locations
3 sites across 1 country: China
Source: ClinicalTrials.gov record NCT04955756. Inclusion in this directory is not an endorsement.